IRF3 and autoimmune disease: Overall, our study reveals a novel function of indomethacin in controlling type I IFN production by regulating IRF3 nuclear translocation and provides a potential treatment for cytosolic nucleic acid-mediated autoimmune diseases (Figure 6O).